Skip to main content

Andembry

Pronunciation: An-DEM-bree
Generic name: garadacimab-gxii
Brand name: Andembry
Dosage form: single-dose prefilled autoinjector for subcutaneous use (200 mg/1.2mL), single-dose prefilled syringe for subcutaneous use (200 mg/1.2 mL)

Medically reviewed by Carmen Pope, BPharm. Last updated on Jun 18, 2025.

What is Andembry?

Andembry is used to prevent attacks of Hereditary Angioedema (HAE) in adults and children 12 years and older. It is given by subcutaneous injection once a month. You can be taught how to self-administer it yourself or a caregiver can give it to you.

Andembry works by inhibiting activated Factor XII, the first factor in the contact activation pathway that triggers bradykinin production. By blocking FXIIa, it prevents prekallikrein activation to kallikrein and reduces bradykinin generation, thereby preventing the inflammatory cascade causing HAE attacks. Andembry belongs to the drug class called activated Factor XII (FXIIa) inhibitors. It is also a monoclonal antibody.

Andembry (aradacimab-gxii) gained FDA approval on June 16, 2025, based on positive results from the placebo-controlled Phase 3 VANGUARD trial (NCT04656418), which demonstrated:

Side effects

The most common side effects of Andembry include:

It is not known if Andembry is safe and effective in children under 12 years of age

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Andembry. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before use

Before you use Andembry, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Andembry?

See the detailed Instructions for Use that come with this Andembry Package Insert about the right way to prepare and inject Andembry. Use it exactly as your healthcare provider tells you to use it.

Your healthcare provider should show you or your caregiver how to prepare and inject your dose of Andembry before you inject yourself for the first time.

Before using the prefilled syringe or autoinjector

Andembry prefilled syringe

This prefilled syringe works differently from other injection devices. Read the Instructions for Use carefully before using it, and each time you get a new prefilled syringe. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.

Make sure you have been trained by your healthcare provider before you use this prefilled syringe for the first time.

Andembry autoinjector

The autoinjector contains 1 dose and is for one-time use only. Do not try to reuse the same autoinjector.

Do not use the autoinjector if it has dropped, looks damaged, has cracks, or is leaking medicine. Throw away the autoinjector in an FDA-approved sharps bin.

To use the autoinjector:

Dosing information

Dose of Andembry for HAE in patients 12 years and older

What other drugs will affect Andembry?

Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

Andembry can prolong activated partial thromboplastin time (aPTT) due to an interaction of garadacimab-gxii with the aPTT assay.

These are not all the possible drug interactions reported with Andembry. Talk to your healthcare provider about drug interactions.

Storage

Store Andembry prefilled syringes and autoinjectors in a refrigerator, between 36˚F to 46˚F (2˚C to 8˚C), in its original carton box until use, to protect it from light.

What are the ingredients in Andembry?

Active ingredient: garadacimab-gxii

Inactive ingredients: arginine monohydrochloride, histidine, polysorbate 80, proline, water for injection.

Andembry injection is available as:

Company

Andembry is manufactured by CSL Behring LLC, King of Prussia, PA 19406, for CSL Behring GmbH Emil-von-Behring-Strasse 76, 35041 Marburg, Germany.

More about garadacimab

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.